# The Effect of Glucose Level and Diabetes Mellitus on Ctrough of Olaparib

> **NCT05081765** · — · UNKNOWN · sponsor: **Poznan University of Medical Sciences** · enrollment: 40 (estimated)

## Conditions studied

- Ovary Cancer

## Interventions

- **DRUG:** Lynparza® (AstraZeneca Pharma Poland Sp. z o.o.)
- **DEVICE:** Lynparza

## Key facts

- **NCT ID:** NCT05081765
- **Lead sponsor:** Poznan University of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-09-20
- **Primary completion:** 2022-10-15
- **Final completion:** 2022-12-31
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2021-10-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05081765

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05081765, "The Effect of Glucose Level and Diabetes Mellitus on Ctrough of Olaparib". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05081765. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*